Telegraph Hill Partners
SEC exempt reporting adviser (venture capital exemption).
- Website
- HTTP://WWW.THPARTNERS.NET
- HQ
- CA
Telegraph Hill Partners partners with private life science and healthcare companies that have novel technologies, a solid customer base, and innovative management teams. Its portfolio includes Promptly, which streamlines patient engagement; EditCo, which develops CRISPR guide RNA designs and edited cells; Argonaut Manufacturing Services, which expands aseptic pharmaceutical fill and finish capabilities; Accumetrics, which makes point of care diagnostics; and Nimble Therapeutics, which applies chemical synthesis to drug discovery. J. Matthew Mackowski serves as Chairman and Managing Director.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Growth, Series A, Series B |
| Sectors | Healthtech, Biotech, Medical devices | Not enough dated deals | Healthtech, Biotech, Medical devices, Manufacturing |
| Regions | Not stated | Not enough dated deals | CA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2003 | 1 | Healthtech, Manufacturing, Medical devices |
| 2004 | 1 | Biotech, Manufacturing, Medical devices |
| 2006 | 2 | Biotech, Healthtech, Medical devices |
| 2007 | 5 | Biotech, Healthtech, Medical devices |
| 2008 | 3 | Medical devices, Biotech, Consumer |
| 2009 | 2 | Healthtech, Medical devices, Biotech |
| 2010 | 2 | Healthtech, Medical devices, Biotech |
| 2011 | 1 | Biotech, Healthtech, Medical devices |
| 2012 | 1 | Biotech, Healthtech, Medical devices |
| 2015 | 1 | Biotech, Healthtech |
| 2016 | 1 | Enterprise SaaS, Logistics |
| 2017 | 3 | Healthtech, Medical devices, Biotech |
| 2018 | 2 | Biotech, Healthtech, Devtools |
| 2019 | 4 | Healthtech, Biotech, Medical devices |
| 2020 | 2 | Biotech, Devtools, Healthtech |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Telegraph Hill Partners V, L.P. Telegraph Hill Partners is a venture firm founded in 2001 that partners with private life science and healthcare companies with novel technologies, solid customer bases, and innovative management teams. It focuses on discovery tools, automation, diagnostics, healthcare IT, and medical devices, offering growth equity, buyouts, and capital. Inferred from the firm's website | approx. 2022 | $525M (Form D) | Late investment period |
03 · People across funds
- J. Mackowski, Member of the Managing Member of the General Partner.
Telegraph Hill Partners V, L.P. (Named on Form D)
- Alexander Herzick, Partner
- Anna Constantine, Associate
- Deval Lashkari, Ph.D., Senior Partner
- J. Matthew Mackowski, Chairman, Managing Director
- Jackson SAvage, Associate
- Jeanette Welsh, J.D., Partner, CFO, COO
- Paul Grossman, Ph.D., Partner
- Rob Capone, Partner
- Rob Hart, J.D., CFA, Partner
- Robert Shepler, Partner Emeritus
- Thomas Raffin, M.D., Partner Emeritus
- Brett Williams, Senior Advisor
On the team page, not linked to a fund
- Gary Curtis, Senior Advisor
On the team page, not linked to a fund
- Peter Dansky, Senior Advisor
On the team page, not linked to a fund
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
- InvestmentNews & Announcements - Telegraph Hill PartnersUndated
- InvestmentNews & Announcements - Telegraph Hill PartnersUndated
06 · Sources
- HTTP://WWW.THPARTNERS.NET
- https://thpartners.net/contact-us/
- https://thpartners.net/meet-the-team/
- https://thpartners.net/news/
- https://thpartners.net/
- https://thpartners.net/news/3/
- https://thpartners.net/portfolio/
- https://thpartners.net/news/2/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026